Stock APRE APREA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Aprea Therapeutics, Inc.

Equities

APRE

US03836J2015

Delayed Nasdaq
Other stock markets
 12:30:44 2024-04-29 pm EDT 		5-day change 1st Jan Change
5.256 USD +1.07% Intraday chart for Aprea Therapeutics, Inc. +2.65% +11.82%
Apr. 10 Aprea Therapeutics, Inc. Announces Presentations on Its Next Generation Wee1 Inhibitor, Apr-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024 CI
Mar. 27 Wedbush Raises Aprea Therapeutics' PT to $11 From $9 After Layering In Recent Financing, Maintains Outperform Rating MT

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APRE Stock
  4. News Aprea Therapeutics, Inc.
  5. MarketScreener Strategies